Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS

Standard

Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS. / Hodecker, Sibylle C; Stürner, Klarissa H; Becker, Veit; Elias-Hamp, Birte; Holst, Brigitte; Friese, Manuel A; Heesen, Christoph.

In: NEUROL-NEUROIMMUNOL, Vol. 4, No. 2, 03.2017, p. e325.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{530c7565b8ad4f1cba9e033bca77fd96,
title = "Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS",
keywords = "Journal Article",
author = "Hodecker, {Sibylle C} and St{\"u}rner, {Klarissa H} and Veit Becker and Birte Elias-Hamp and Brigitte Holst and Friese, {Manuel A} and Christoph Heesen",
year = "2017",
month = mar,
doi = "10.1212/NXI.0000000000000325",
language = "English",
volume = "4",
pages = "e325",
journal = "NEUROL-NEUROIMMUNOL",
issn = "2332-7812",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

RIS

TY - JOUR

T1 - Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS

AU - Hodecker, Sibylle C

AU - Stürner, Klarissa H

AU - Becker, Veit

AU - Elias-Hamp, Birte

AU - Holst, Brigitte

AU - Friese, Manuel A

AU - Heesen, Christoph

PY - 2017/3

Y1 - 2017/3

KW - Journal Article

U2 - 10.1212/NXI.0000000000000325

DO - 10.1212/NXI.0000000000000325

M3 - SCORING: Journal article

C2 - 28210661

VL - 4

SP - e325

JO - NEUROL-NEUROIMMUNOL

JF - NEUROL-NEUROIMMUNOL

SN - 2332-7812

IS - 2

ER -